Drugs / HER-2-neu
last change Feb 2008 re-read 2 minutes ago

HER-2-neu

Developed for
colorectal cancer
Investigated by
Craig L Slingluff, Jr · National Cancer Institute (NCI)

Trials 1 · a red edge is where a trial was stopped

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT00091286 Mar 2003 → Feb 2008 colorectal cancer Craig L Slingluff, Jr Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HER-2-neu ClinicalTrials.gov intervention name — accepted as the source's own label NCT00091286